LAWSUITS NEWS & LEGAL INFORMATION
Nearly 700 Avandia Victims Settle with GSK
This is a settlement for the Avandia lawsuit.
Washington, DC: Nearly 700 people who are suing drug maker GlaxoSmithKline in three separate lawsuits alleging severe adverse events connected with the diabetes medication Avandia, are reportedly settling with the company for nearly $60 million.
Avandia, also known as rosiglitazone maleate, was developed to treat type 2 diabetes mellitus. First approved by the FDA in 1999, the agency reported eight years later a significant increase in the risk of heart attack in those patients to whom Avandia had been prescribed. And many deaths have been linked to Avandia. More recently, two independent studies showed that bone fractures, particularly in female patients, have been associated with this popular diabetes drug, while a third study has found a link between Avandia and liver failure.
Lawyers representing the plaintiffs allege their clients suffered heart attacks, stroke, and congestive heart failure as a result of taking the drug.
Published on May-11-10
Avandia, also known as rosiglitazone maleate, was developed to treat type 2 diabetes mellitus. First approved by the FDA in 1999, the agency reported eight years later a significant increase in the risk of heart attack in those patients to whom Avandia had been prescribed. And many deaths have been linked to Avandia. More recently, two independent studies showed that bone fractures, particularly in female patients, have been associated with this popular diabetes drug, while a third study has found a link between Avandia and liver failure.
Lawyers representing the plaintiffs allege their clients suffered heart attacks, stroke, and congestive heart failure as a result of taking the drug.
Legal Help
If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.Published on May-11-10
